DirexGroup
7 News & Press Releases found

DirexGroup news

The third presentation on the latest treatment approach for Female Sexual Dysfunction (FSD), by Transvaginal Shockwave Therapy (TVST), is to be presented this week at the upcoming European Society of Sexual Medicine. Session PS-01 will be presented by Laszlo Kornya, MD at the upcoming 23rd ESSM Annual Meeting, on Friday, February 18, 2022, at 10:21 AM, in Virtual Room 2 (VR-2).  Exhibition this year has gone virtual and will take place on-line only. Dr. Kornya will share his exper

Feb. 6, 2022

An exclusive and limited offer is presently being offered to clinics interested in offering treatment. Demo proposal is for a three month period and incorporates minimum 10 patient treatments, of 10 short sessions in 5 days, and follow-up p/p. Micro is the latest MoreNova model, offering patented Large Area Shockwave Technology for treating medical and cosmetic conditions. A small, light and powerful Energizer (console,
Feb. 6, 2021

"One of the repercussions of COVID-19 is its impact on men`s sexual health.  COVID-19 infection is expected to be associated with an increased likelihood of erectile dysfunction (ED).  Considering the high transmissibility of COVID-19, ED could be a concerning consequence for a large segment of the population" https://www.ncbi.nim.nih.gov/pmc/articles/PMC8450276/. Coincidentally, DirexGroup introduces MoreNova

May. 0, 2022

The first of three already conducted clinical pilots, relate to using MoreNova for female Sexual Improvement and Stress Urinary Incontinence. The pilots presented at the International Continence Society (ICS) 2021 Melbourne conference. Treatment was offered to women suffering from stress urinary incontinence, sexual dysfunction or both conditions.  Initial results are highly encouraging.  Low intensity shockwaves promote angiogenesis, increase nitric oxide release (NO), induc

Oct. 4, 2021

MoreNova Turbo (MT) is a shockwaves device incorporating a compact and powerful energizer, in-line ultrasound localizer and easily interchangeable high-efficiency applicators. The novel applicators are designed to respectively deliver point, linear or planar shockwaves compatible with treating urinary stones, calcified leg arteries, prostate, Chronic Kidney Disease (CKD) and more. Target localization in various patient positions is achieved by motorized and manual applicator’s mo

Feb. 6, 2021

Contact supplier

Drop file here or browse